|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||
REVIEWS AND ORIGINAL ARTICLES |
From the Univ. Southern California Med Ctr, L.A. Ca 90033(1) , Hurley Med Ctr, Flint Mich 48502(2) , 30 Alson Ave, New Haven Conn. 60515(3) ,3034 Old Clinic Bldg, Chapel Hill, N. Carolina 27514 (4) , Arizona Hlth Sci Ctr, Tucson Az 85724(5) , UCSO Medical Center, San Diego, Ca 92103(6) , and Toronto Western Hospital, Toronto, Canada(7) .
Most reports indicate that in patients on CAPD, hyperparathyroid bone
disease progresses, while osteomalacia improves. With 1.5g% Dianeal, and when
dialysate Ca is 7mg%, peritoneal mass transfer of calcium is positive, i.e.,
it is absorbed from the solution, while with hypertonic solutions it is less
positive or even negative. Daily phosphorus removal by CAPD is insufficient to
control serum phosphorus, hence CAPD patients require phosphate binders and/or
phosphate restriction. Peritoneal phosphorus removal is greater with
hypertonic than with isotonic solutions.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |